Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dimosthenis V, Skarlos"'
Autor:
Maria Vassilakopoulou, Taiwo Togun, Urania Dafni, Huan Cheng, Jennifer Bordeaux, Veronique M Neumeister, Mattheos Bobos, George Pentheroudakis, Dimosthenis V Skarlos, Dimitrios Pectasides, Vassiliki Kotoula, George Fountzilas, David L Rimm, Amanda Psyrri
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99131 (2014)
We sought to determine the predictive value of in situ mRNA measurement compared to traditional methods on a cohort of trastuzumab-treated metastatic breast cancer patients.A tissue microarray composed of 149, classified as HER2-positive, metastatic
Externí odkaz:
https://doaj.org/article/39507788764544b193acd5dff1a36f26
Autor:
George Fountzilas, Vassiliki Kotoula, Dimitrios Pectasides, George Kouvatseas, Eleni Timotheadou, Mattheos Bobos, Xanthipi Mavropoulou, Christos Papadimitriou, Eleni Vrettou, Georgia Raptou, Angelos Koutras, Evangelia Razis, Dimitrios Bafaloukos, Epaminontas Samantas, George Pentheroudakis, Dimosthenis V Skarlos
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e69256 (2013)
To explore the activity and safety of two schedules of ixabepilone, as first line chemotherapy, in patients with metastatic breast cancer previously treated with adjuvant chemotherapy, a randomized non-comparative phase II study was conducted. From N
Externí odkaz:
https://doaj.org/article/f6f0fb98581f4d6290390420788ff9a3
Autor:
George Fountzilas, Urania Dafni, Mattheos Bobos, Anna Batistatou, Vassiliki Kotoula, Helen Trihia, Vassiliki Malamou-Mitsi, Spyros Miliaras, Sofia Chrisafi, Savvas Papadopoulos, Maria Sotiropoulou, Theodoros Filippidis, Helen Gogas, Triantafyllia Koletsa, Dimitrios Bafaloukos, Despina Televantou, Konstantine T Kalogeras, Dimitrios Pectasides, Dimosthenis V Skarlos, Angelos Koutras, Meletios A Dimopoulos
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e37946 (2012)
BACKGROUND: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes d
Externí odkaz:
https://doaj.org/article/133daa9f385e4d3e8fd3bdaca49badd4
Autor:
Helen P, Kourea, Vassiliki, Kotoula, Angelos, Koutras, Zoi, Alexopoulou, Irene, Papaspirou, Dimosthenis V, Skarlos, Ioannis, Efstratiou, Mattheos, Bobos, Flora, Zagouri, Pavlos, Papakostas, Dimitrios, Pectasides, Sofia, Chrisafi, Ioannis, Varthalitis, Gerasimos, Aravantinos, Paris, Kosmidis, Dimitrios, Bafaloukos, Chrisoula D, Scopa, George, Fountzilas
Publikováno v:
Histology and histopathology. 30(9)
Metronomic taxane administration has putative antiangiogenic properties. Herein, we examined the baseline tumor angiogenic profile of patients with metastatic breast carcinoma (MBC) in a prospective-retrospective translational research study. The int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::456e85d023648b6bffb4928c1dfce133
https://pubmed.ncbi.nlm.nih.gov/25807307
https://pubmed.ncbi.nlm.nih.gov/25807307
Autor:
Christos, Christodoulou, Ioannis, Kostopoulos, Haralabos P, Kalofonos, Evangelos, Lianos, Mattheos, Bobos, Evangelos, Briasoulis, Helen, Gogas, Evangelia, Razis, Dimosthenis V, Skarlos, George, Fountzilas
Publikováno v:
Oncology. 76(4)
Combination of trastuzumab and anthracyclines in metastatic breast cancer (MBC) is precluded due to cardiotoxicity. Pegylated liposomal doxorubicin (PLD) is the least cardiotoxic among the anthracyclines. We performed a phase II study of trastuzumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe0623822a48fb0f9d5988c10b335ae8
https://pubmed.ncbi.nlm.nih.gov/19262067
https://pubmed.ncbi.nlm.nih.gov/19262067
Autor:
Dimosthenis V, Skarlos, Maria, Bai, Anna, Goussia, Epaminontas, Samantas, Eleni, Galani, Dimitrios, Tsavdaridis, Maria, Karina, Pavlos, Papakostas, Athina, Konstantara, George, Fountzilas
Publikováno v:
Anticancer research. 27(4C)
This study evaluated the prognostic role of vascular epidermal growth factor (VEGF), thymidylate synthase (TS), topoisomerase I (Topo-I), topoisomerase IIalpha (Topo-IIalpha) and E-cadherin (E-cadh) tumor expression, in patients with resectable gastr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbc8360429b7ea8ca782ba554bdc0985
https://pubmed.ncbi.nlm.nih.gov/17695481
https://pubmed.ncbi.nlm.nih.gov/17695481
Autor:
Dimosthenis V, Skarlos, Haralabos P, Kalofonos, George, Fountzilas, Meletios A, Dimopoulos, Nicholas, Pavlidis, Evangelia, Razis, Theofanis, Economopoulos, Dimitrios, Pectasides, Helen, Gogas, Paris, Kosmidis, Dimitrios, Bafaloukos, George, Klouvas, George, Kyratzis, Gerasimos, Aravantinos
Publikováno v:
Anticancer research. 25(4)
A phase II study was conducted to evaluate the efficacy and toxicity of the combination of gemcitabine (GEM) and pegylated liposomal doxorubicin (PLD) in patients with platinum- and/or taxane-resistant/refractory advanced epithelial ovarian cancer (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8df55cb60e33c9072f666a3b619dcfc2
https://pubmed.ncbi.nlm.nih.gov/16080573
https://pubmed.ncbi.nlm.nih.gov/16080573
Autor:
Aristotle T, Bamias, Maria C, Bai, Niki J, Agnantis, Michael C, Michael, Yiannis P, Alamanos, Stella V, Stefanaki, Evagelia D, Razi, Dimosthenis V, Skarlos, Angelos M, Kappas, Nicholas A, Pavlidis
Publikováno v:
Cancer investigation. 21(3)
The deleted in colorectal cancer (DCC) gene is a candidate tumor suppressor gene that may be associated with differentiation and proliferation of normal cells. Loss of heterozygosity (LOH) of 18q, where the gene is located, and absence of DCC protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea51be75be130552db0d698265f4b950
https://pubmed.ncbi.nlm.nih.gov/12901278
https://pubmed.ncbi.nlm.nih.gov/12901278